Amplification of Positivity for Alcohol Use Disorder Co-Occurring With Anxiety or Depression
Public ClinicalTrials.gov record NCT04934553. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Amplification of Positivity for Alcohol Use Disorder (AMP-A): Feasibility and Pilot Study
Study identification
- NCT ID
- NCT04934553
- Recruitment status
- Suspended
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Charles Taylor
- Other
- Enrollment
- 20 participants
Conditions and interventions
Conditions
Interventions
- Amplification of Positivity Training Behavioral
- Cognitive-behavioral Therapy Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 19, 2021
- Primary completion
- Dec 31, 2022
- Completion
- May 31, 2023
- Last update posted
- Apr 19, 2022
2021 – 2023
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Altman Clinical and Translational Research Institute | La Jolla | California | 92037 | — |
| Laureate Institute for Brain Research | Tulsa | Oklahoma | 74136 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04934553, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 19, 2022 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04934553 live on ClinicalTrials.gov.